DermTech Other Current Liab vs Total Stockholder Equity Analysis

DMTK Stock

USD 0.50 0.07 12.28%

DermTech financial indicator trend analysis is much more than just examining DermTech latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DermTech is a good investment. Please check the relationship between DermTech Other Current Liab and its Total Stockholder Equity accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.

Other Current Liab vs Total Stockholder Equity

Other Current Liab vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DermTech Other Current Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between DermTech's Other Current Liab and Total Stockholder Equity is 0.58. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of DermTech, assuming nothing else is changed. The correlation between historical values of DermTech's Other Current Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of DermTech are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Other Current Liab i.e., DermTech's Other Current Liab and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.58

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Current Liab

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from DermTech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DermTech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.Selling General Administrative is expected to rise to about 46 M this year, although the value of Issuance Of Capital Stock will most likely fall to about 5 M.

DermTech fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Property Plant Equipment	Net Debt	Net Receivables	Net Invested Capital
Total Assets		0.73	0.72	0.97	0.82	-0.62	0.72	0.85	0.61	0.28	0.71	0.45	0.87	0.28	0.72	0.05	0.53	0.67	0.59	-0.13	0.87	0.28	0.83	-0.64	0.87	0.3
Other Current Liab	0.73		0.97	0.58	0.88	-0.96	0.74	0.64	0.32	-0.19	0.95	0.49	0.7	-0.19	0.94	-0.21	0.92	0.95	0.95	-0.35	0.71	-0.19	0.85	-0.23	0.91	-0.05
Total Current Liabilities	0.72	0.97		0.58	0.9	-0.95	0.8	0.69	0.23	-0.25	0.94	0.36	0.74	-0.26	0.91	-0.38	0.86	0.89	0.9	-0.51	0.75	-0.26	0.88	-0.31	0.91	-0.02
Total Stockholder Equity	0.97	0.58	0.58		0.76	-0.46	0.65	0.85	0.57	0.37	0.58	0.42	0.86	0.37	0.61	0.12	0.35	0.5	0.41	-0.06	0.86	0.37	0.78	-0.73	0.77	0.39
Net Tangible Assets	0.82	0.88	0.9	0.76		-0.86	0.78	0.87	0.22	-0.17	0.92	0.46	0.89	-0.18	0.93	-0.18	0.69	0.75	0.75	-0.34	0.89	-0.18	1.0	-0.57	0.93	0.2
Retained Earnings	-0.62	-0.96	-0.95	-0.46	-0.86		-0.63	-0.53	-0.28	0.2	-0.96	-0.42	-0.58	0.22	-0.93	0.31	-0.93	-0.88	-0.95	0.42	-0.59	0.22	-0.82	0.1	-0.81	0.11
Accounts Payable	0.72	0.74	0.8	0.65	0.78	-0.63		0.81	0.06	-0.27	0.64	0.35	0.85	-0.28	0.68	-0.45	0.48	0.6	0.55	-0.6	0.85	-0.28	0.79	-0.63	0.86	-0.14
Cash	0.85	0.64	0.69	0.85	0.87	-0.53	0.81		0.11	-0.15	0.65	0.31	0.99	-0.15	0.68	-0.1	0.33	0.51	0.42	-0.28	0.98	-0.15	0.9	-0.89	0.86	0.41
Non Current Assets Total	0.61	0.32	0.23	0.57	0.22	-0.28	0.06	0.11		0.85	0.33	0.36	0.14	0.84	0.25	0.29	0.42	0.39	0.4	0.24	0.14	0.84	0.21	0.07	0.28	0.03
Non Currrent Assets Other	0.28	-0.19	-0.25	0.37	-0.17	0.2	-0.27	-0.15	0.85		-0.15	0.17	-0.16	1.0	-0.2	0.4	-0.08	-0.13	-0.11	0.43	-0.17	1.0	-0.16	0.09	-0.18	0.07
Other Assets	0.71	0.95	0.94	0.58	0.92	-0.96	0.64	0.65	0.33	-0.15		0.46	0.68	-0.16	0.94	-0.19	0.91	0.9	0.94	-0.31	0.69	-0.16	0.9	-0.24	0.87	0.07
Long Term Debt	0.45	0.49	0.36	0.42	0.46	-0.42	0.35	0.31	0.36	0.17	0.46		0.35	0.15	0.64	0.47	0.44	0.42	0.43	0.4	0.35	0.15	0.46	-0.14	0.44	-0.3
Cash And Short Term Investments	0.87	0.7	0.74	0.86	0.89	-0.58	0.85	0.99	0.14	-0.16	0.68	0.35		-0.16	0.73	-0.1	0.39	0.58	0.47	-0.3	1.0	-0.16	0.9	-0.84	0.91	0.36
Common Stock Total Equity	0.28	-0.19	-0.26	0.37	-0.18	0.22	-0.28	-0.15	0.84	1.0	-0.16	0.15	-0.16		-0.21	0.42	-0.09	-0.14	-0.13	0.44	-0.16	1.0	-0.17	0.08	-0.18	0.11
Common Stock Shares Outstanding	0.72	0.94	0.91	0.61	0.93	-0.93	0.68	0.68	0.25	-0.2	0.94	0.64	0.73	-0.21		-0.04	0.83	0.85	0.87	-0.19	0.74	-0.21	0.91	-0.31	0.88	0.02
Short Term Investments	0.05	-0.21	-0.38	0.12	-0.18	0.31	-0.45	-0.1	0.29	0.4	-0.19	0.47	-0.1	0.42	-0.04		-0.2	-0.13	-0.23	0.97	-0.11	0.42	-0.16	0.01	-0.17	0.33
Non Current Liabilities Total	0.53	0.92	0.86	0.35	0.69	-0.93	0.48	0.33	0.42	-0.08	0.91	0.44	0.39	-0.09	0.83	-0.2		0.94	0.99	-0.27	0.4	-0.09	0.65	0.14	0.72	-0.18
Inventory	0.67	0.95	0.89	0.5	0.75	-0.88	0.6	0.51	0.39	-0.13	0.9	0.42	0.58	-0.14	0.85	-0.13	0.94		0.96	-0.26	0.59	-0.14	0.71	-0.07	0.86	0.0
Total Liab	0.59	0.95	0.9	0.41	0.75	-0.95	0.55	0.42	0.4	-0.11	0.94	0.43	0.47	-0.13	0.87	-0.23	0.99	0.96		-0.32	0.49	-0.13	0.72	0.05	0.78	-0.13
Long Term Investments	-0.13	-0.35	-0.51	-0.06	-0.34	0.42	-0.6	-0.28	0.24	0.43	-0.31	0.4	-0.3	0.44	-0.19	0.97	-0.27	-0.26	-0.32		-0.31	0.44	-0.32	0.16	-0.35	0.24
Total Current Assets	0.87	0.71	0.75	0.86	0.89	-0.59	0.85	0.98	0.14	-0.17	0.69	0.35	1.0	-0.16	0.74	-0.11	0.4	0.59	0.49	-0.31		-0.16	0.91	-0.83	0.92	0.35
Common Stock	0.28	-0.19	-0.26	0.37	-0.18	0.22	-0.28	-0.15	0.84	1.0	-0.16	0.15	-0.16	1.0	-0.21	0.42	-0.09	-0.14	-0.13	0.44	-0.16		-0.17	0.08	-0.18	0.11
Property Plant Equipment	0.83	0.85	0.88	0.78	1.0	-0.82	0.79	0.9	0.21	-0.16	0.9	0.46	0.9	-0.17	0.91	-0.16	0.65	0.71	0.72	-0.32	0.91	-0.17		-0.62	0.92	0.23
Net Debt	-0.64	-0.23	-0.31	-0.73	-0.57	0.1	-0.63	-0.89	0.07	0.09	-0.24	-0.14	-0.84	0.08	-0.31	0.01	0.14	-0.07	0.05	0.16	-0.83	0.08	-0.62		-0.55	-0.49
Net Receivables	0.87	0.91	0.91	0.77	0.93	-0.81	0.86	0.86	0.28	-0.18	0.87	0.44	0.91	-0.18	0.88	-0.17	0.72	0.86	0.78	-0.35	0.92	-0.18	0.92	-0.55		0.16
Net Invested Capital	0.3	-0.05	-0.02	0.39	0.2	0.11	-0.14	0.41	0.03	0.07	0.07	-0.3	0.36	0.11	0.02	0.33	-0.18	0.0	-0.13	0.24	0.35	0.11	0.23	-0.49	0.16

Click cells to compare fundamentals

DermTech Account Relationship Matchups

DermTech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.2M	69.8M	248.3M	202.1M	121.9M	82.3M
Other Current Liab	2.7M	2.8M	6.3M	11.4M	8.7M	9.1M
Total Current Liabilities	5.7M	5.4M	12.2M	15.6M	13.4M	14.1M
Total Stockholder Equity	12.5M	63.5M	229.7M	132.4M	57.2M	64.2M
Net Tangible Assets	12.5M	63.5M	229.7M	132.4M	152.2M	159.8M
Retained Earnings	(91.1M)	(126.4M)	(206.4M)	(323.0M)	(423.9M)	(402.7M)
Accounts Payable	1.6M	1.6M	2.9M	2.4M	1.5M	1.2M
Cash	15.4M	24.2M	176.9M	77.8M	36.7M	33.4M
Non Current Assets Total	1.1M	2.9M	15.5M	66.0M	60.2M	30.5M
Non Currrent Assets Other	12.4M	84K	167K	168K	3.5M	3.3M
Other Assets	84K	167K	3.2M	3.7M	4.2M	4.4M
Cash And Short Term Investments	15.4M	63.8M	225.3M	126.2M	55.9M	48.7M
Common Stock Total Equity	4.1M	1K	2K	3K	2.7K	2.6K
Common Stock Shares Outstanding	7.0M	17.0M	28.9M	30.0M	32.6M	34.3M
Short Term Investments	12.4M	39.5M	48.4M	48.4M	19.1M	18.2M
Liabilities And Stockholders Equity	18.2M	69.8M	248.3M	202.1M	121.9M	82.0M
Capital Surpluse	103.6M	189.8M	436.2M	456.2M	524.6M	550.8M
Inventory	35K	104K	480K	1.8M	1.0M	1.1M
Other Current Assets	1.1M	1.5M	3.2M	3.9M	2.3M	1.3M
Other Stockholder Equity	103.6M	120.1M	436.2M	456.2M	480.9M	505.0M
Total Liab	5.7M	6.3M	18.6M	69.7M	64.8M	68.0M
Property Plant And Equipment Gross	977K	2.7M	12.3M	6.4M	60.5M	63.5M
Total Current Assets	17.2M	66.9M	232.8M	136.0M	61.8M	51.8M
Accumulated Other Comprehensive Income	(239K)	(1K)	(124K)	(774K)	178K	186.9K
Common Stock	4.1M	1K	2K	3K	2.7K	2.6K
Property Plant Equipment	977K	2.7M	12.3M	6.4M	7.3M	7.7M
Net Debt	(15.4M)	(23.9M)	(169.0M)	(21.9M)	17.7M	18.5M
Net Invested Capital	12.5M	63.5M	229.7M	132.4M	57.2M	101.0M
Net Working Capital	11.4M	61.5M	220.6M	120.4M	48.3M	72.5M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as DermTech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether DermTech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DermTech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dermtech Stock. Highlighted below are key reports to facilitate an investment decision about Dermtech Stock:

How To Invest In DermTech

Details

Is DermTech Stock a good investment?

Details

What is DermTech's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for DermTech Stock analysis

When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.

	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Transaction History View history of all your transactions and understand their impact on performance
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world

Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.09)

Revenue Per Share

0.465

Quarterly Revenue Growth

0.106

Return On Assets

(0.39)

Return On Equity

(1.22)

The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DermTech Other Current Liab vs Total Stockholder Equity Analysis

Other Current Liab vs Total Stockholder Equity

Other Current Liab vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Other Current Liab

Total Stockholder Equity

DermTech fundamental ratios Correlations

DermTech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DermTech fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for DermTech Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant Equipment	+ 1.0	Net Tangible Assets
Common Stock Total Equity	+ 1.0	Non Currrent Assets Other
Common Stock	+ 1.0	Non Currrent Assets Other
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 0.99	Cash

Other Assets	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Other Current Liab
Total Liab	- 0.95	Retained Earnings
Retained Earnings	- 0.95	Total Current Liabilities
Non Current Liabilities Total	- 0.93	Retained Earnings
Common Stock Shares Outstanding	- 0.93	Retained Earnings